A similar trend of differential NAV3 expression, with low levels observed in cells residing within the tumor sphere core and higher levels in cells at the tumor spheroid edges, respectively, was also detected in our samples from both established GBM cell lines and patient‐derived GSC cultures. This evidence concerns the gene NAV3 and neoplasm.